Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BUY RDOC -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (37)	5/12/1998 10:53:00 PM
From: Jasman	Read Replies (1) \| Respond to of 130

I wouldn't go that far... IBM and University of California at Davis are codevelopers of RDOC's technology and so they both have a big stake. Anything more will be pure speculation.

To: Dennis who wrote (37)	5/12/1998 11:11:00 PM
From: Volsi Mimir	Read Replies (1) \| Respond to of 130

IBM's possible role with RDOC (scroll down for bold type): from same SEC file: www4.edgar-online.com. EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES The names, ages and business backgrounds of the executive officers and other significant employees of the Company who are not nominees for Director are as follows: MARK W. WINN, 47, has been Chief Financial Officer and Secretary of the Company since September 1997. Mr. Winn served as the Senior Vice President and Chief Financial Officer of Research Medical, Inc. (a manufacturer and developer of specialty cardiovascular and pharmaceutical products) from November 1991 to August 1997. Mr. Winn was the Vice President and Chief Financial Officer of Gory Associated Industries (a South Florida building products manufacturer) from 1984 to 1991. LELAND WITHERSPOON, 45, has been Vice President, Engineering since April 1997. Mr. Witherspoon was Director Product Research and Development for Sorin Biomedicals, Inc. (a developer and manufacturer of cardiopulmonary and cardiovascular products) from February 1992 to April 1997. He was Manager of Research and Development for Pfizer/Shiley (a developer and manufacturer of cardiopulmonary and cardiovascular equipment and disposables) from February 1992 to April 1997. Mr. Witherspoon held various technical and management positions with Xerox Medical Systems (a manufacturer and developer of diagnostic medical electronic and mechanical systems) from March 1979 to October 1990. PETER KAZANZIDES, PH.D., 35, a co-founder of the Company, has been an employee of the Company since November 1990 and Director of Robotics and Software of the Company since December 1995. He received Sc.B., Sc.M., and Ph.D. degrees in electrical engineering from Brown University in 1983, 1985, and 1988, respectively. His dissertation focused on force control and multiprocessor systems for robotics. He performed post-doctoral research in surgical robotics from March 1989 to March 1990 at the IBM T.J. Watson Research Center. BRENT D. MITTELSTADT, 38, a co-founder of the Company, has been an employee of the Company since November 1990 and Director of Surgical Applications of the Company since December 1995. He began research in surgical robotics in 1986 as a visiting research scientist at the IBM T.J. Watson Research Center and is responsible for much of the early development of CT guided robotic systems for total hip replacement surgery. HANS WEYENSCHENK, 47, has been Director of Marketing, Orthopaedics, of the Company since February 1997. Prior thereto, he was employed by Vitatron Medical, Inc., a wholly-owned subsidiary of Medtronics (a manufacturer of cardiac products), as Director of Marketing, Communications and Services from 1996 to February 1997 and Director of International Sales from 1987 to 1995. JEROME LEBON, 42, has been Director of Marketing, Neurosurgery of the Company since September 5, 1997. He was Executive Vice President of International Sales of Innovative Medical Machines International, S.A. (a manufacturer and distributor of neurosurgical products), which the Company acquired in September 16 1997, from 1996 until September 1997. He was International Vice President of Technomed International (a lithrotripsy company in France) from 1987 to 1995. JEFFREY A. JOHNSON, 46, has been Director of Marketing, U.S.A. of the Company since June 1997. Mr. Johnson was Marketing Manager for Sorin Biomedical, Inc. (a developer and manufacturer of cardiopulmonary and cardiovascular equipment) from 1992 to June 1997. Mr. Johnson was a Product Manager for the Ultrasound division of Philips Medical Systems, Inc. from 1984 to 1991. KENNETH M. SAN VINCENTE, 37, has been Director of Software Systems of the Company since July 1997. Mr. San Vincente was Software Engineering Manager for EndoSonics Corporation (a developer and manufacturer of intravascular ultrasound equipment) from 1994 to June 1997 and a project engineering manager for the Control Systems Division of Parker Hannifin Corporation from 1989 to 1993.